Ridgewood Investments’s Emergent Biosolutions EBS Stock Holding History

Ridgewood Investments’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-10,004	Closed	-$63.8K	–	339
2025 Q2	$63.8K	Hold	10,004	–	–	0.03%	300
2025 Q1	$48.6K	Hold	10,004	–	–	0.02%	318
2024 Q4	$95.6K	Hold	10,004	–	–	0.05%	240
2024 Q3	$83.5K	Hold	10,004	–	–	0.04%	253
2024 Q2	$68.2K	Hold	10,004	–	–	0.03%	278
2024 Q1	$25.3K	Hold	10,004	–	–	0.01%	187
2023 Q4	$24K	Hold	10,004	–	–	0.01%	179
2023 Q3	$34K	Hold	10,004	–	–	0.02%	166
2023 Q2	$73.5K	Hold	10,004	–	–	0.04%	274
2023 Q1	$104K	Hold	10,004	–	–	0.06%	247
2022 Q4	$118K	Hold	10,004	–	–	0.08%	188
2022 Q3	$210K	Hold	10,004	–	–	0.17%	162
2022 Q2	$311K	Hold	10,004	–	–	0.24%	134
2022 Q1	$411K	Hold	10,004	–	–	0.27%	121
2021 Q4	$435K	Hold	10,004	–	–	0.28%	117
2021 Q3	$501K	Hold	10,004	–	–	0.34%	99
2021 Q2	$630K	Hold	10,004	–	–	0.4%	91
2021 Q1	$929K	Hold	10,004	–	–	0.57%	58
2020 Q4	$1.03M	Hold	10,004	–	–	0.81%	28
2020 Q3	$1.03M	Buy	+10,004	New	+$1.08M	0.81%	28

Other funds holding EBS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

OHA

Oak Hill Advisors New York $878M AUM 106.46% 1-Year Est. Return

PCM

Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Ridgewood Investments's EBS Position: Q3 2025 in Review

Ridgewood Investments sold out of Emergent Biosolutions (EBS) in Q3 2025, closing a stake of 10,004 shares — an estimated $63.8K sold.

Ridgewood Investments first reported a position in EBS in Q3 2020 and held it in 20 quarters. The position peaked at $1.03M in Q4 2020. 169 funds tracked by Wall St. Rank hold EBS as of Q3 2025.

Ridgewood Investments reported no remaining Emergent Biosolutions position as of Q3 2025 after selling out during the quarter.
Ridgewood Investments sold 10,004 Emergent Biosolutions shares in Q3 2025, an estimated $63.8K.
Ridgewood Investments first reported a position in Emergent Biosolutions in Q3 2020 and held it in 20 quarters.
Ridgewood Investments's Emergent Biosolutions position peaked at $1.03M in Q4 2020.
169 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q3 2025.

Based on Ridgewood Investments's 13F filing for Q3 2025, filed 30 Oct 2025.